Literature DB >> 19228676

TDP-43 M311V mutation in familial amyotrophic lateral sclerosis.

R Lemmens, V Race, N Hersmus, G Matthijs, L Van Den Bosch, P Van Damme, B Dubois, S Boonen, A Goris, W Robberecht.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19228676     DOI： 10.1136/jnnp.2008.157677

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  21 in total

Review 1.  Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration.

Authors:  T F Gendron; K A Josephs; L Petrucelli
Journal:  Neuropathol Appl Neurobiol       Date:  2010-02-19       Impact factor: 8.090

Review 2.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

3.  Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis.

Authors:  Brian C Kraemer; Theresa Schuck; Jeanna M Wheeler; Linda C Robinson; John Q Trojanowski; Virginia M Y Lee; Gerard D Schellenberg
Journal:  Acta Neuropathol       Date:  2010-03-03       Impact factor: 17.088

Review 4.  The complex molecular biology of amyotrophic lateral sclerosis (ALS).

Authors:  Rachel L Redler; Nikolay V Dokholyan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 5.  TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43.

Authors:  Tania F Gendron; Rosa Rademakers; Leonard Petrucelli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy.

Authors:  Angela S Laird; Annelies Van Hoecke; Louis De Muynck; Mieke Timmers; Ludo Van den Bosch; Philip Van Damme; Wim Robberecht
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

7.  Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis.

Authors:  Janine Kirby; Emily F Goodall; William Smith; J Robin Highley; Rudo Masanzu; Judith A Hartley; Rachel Hibberd; Hannah C Hollinger; Stephen B Wharton; Karen E Morrison; Paul G Ince; Christopher J McDermott; Pamela J Shaw
Journal:  Neurogenetics       Date:  2009-09-17       Impact factor: 2.660

Review 8.  Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.

Authors:  Felix Geser; Virginia M-Y Lee; John Q Trojanowski
Journal:  Neuropathology       Date:  2010-01-25       Impact factor: 1.906

Review 9.  Rethinking ALS: the FUS about TDP-43.

Authors:  Clotilde Lagier-Tourenne; Don W Cleveland
Journal:  Cell       Date:  2009-03-20       Impact factor: 41.582

10.  Association between novel TARDBP mutations and Chinese patients with amyotrophic lateral sclerosis.

Authors:  Hui-Ling Xiong; Jin-Yang Wang; Yi-Min Sun; Jian-Jun Wu; Yan Chen; Kai Qiao; Qiao-Juan Zheng; Gui-Xian Zhao; Zhi-Ying Wu
Journal:  BMC Med Genet       Date:  2010-01-19       Impact factor: 2.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.